Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK.

AIMS Vascular stiffness, structural elastin abnormalities, and increased oxidative stress are hallmarks of hypertension. Lysyl oxidase (LOX) is an elastin crosslinking enzyme that produces H2O2 as a by-product. We addressed the interplay between LOX, oxidative stress, vessel stiffness, and elastin. RESULTS Angiotensin II (Ang II)-infused hypertensive mice and spontaneously hypertensive rats (SHR) showed increased vascular LOX expression and stiffness and an abnormal elastin structure. Mice over-expressing LOX in vascular smooth muscle cells (TgLOX) exhibited similar mechanical and elastin alterations to those of hypertensive models. LOX inhibition with β-aminopropionitrile (BAPN) attenuated mechanical and elastin alterations in TgLOX mice, Ang II-infused mice, and SHR. Arteries from TgLOX mice, Ang II-infused mice, and/or SHR exhibited increased vascular H2O2 and O2.- levels, NADPH oxidase activity, and/or mitochondrial dysfunction. BAPN prevented the higher oxidative stress in hypertensive models. Treatment of TgLOX and Ang II-infused mice and SHR with the mitochondrial-targeted superoxide dismutase mimetic mito-TEMPO, the antioxidant apocynin, or the H2O2 scavenger polyethylene glycol-conjugated catalase (PEG-catalase) reduced oxidative stress, vascular stiffness, and elastin alterations. Vascular p38 mitogen-activated protein kinase (p38MAPK) activation was increased in Ang II-infused and TgLOX mice and this effect was prevented by BAPN, mito-TEMPO, or PEG-catalase. SB203580, the p38MAPK inhibitor, normalized vessel stiffness and elastin structure in TgLOX mice. INNOVATION We identify LOX as a novel source of vascular reactive oxygen species and a new pathway involved in vascular stiffness and elastin remodeling in hypertension. CONCLUSION LOX up-regulation is associated with enhanced oxidative stress that promotes p38MAPK activation, elastin structural alterations, and vascular stiffness. This pathway contributes to vascular abnormalities in hypertension. Antioxid. Redox Signal. 27, 379-397.

[1]  Manuel F. Navedo,et al.  Arterial Smooth Muscle Mitochondria Amplify Hydrogen Peroxide Microdomains Functionally Coupled to L-Type Calcium Channels. , 2015, Circulation research.

[2]  A. Briones,et al.  Toll‐like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II‐induced hypertension , 2015, British journal of pharmacology.

[3]  T. Secomb,et al.  Effect of Lysyl Oxidase Inhibition on Angiotensin II-Induced Arterial Hypertension, Remodeling, and Stiffness , 2015, PloS one.

[4]  S. Laurent,et al.  The structural factor of hypertension: large and small artery alterations. , 2015, Circulation research.

[5]  E. Lakatta,et al.  The Conundrum of Arterial Stiffness, Elevated Blood Pressure, and Aging , 2015, Current Hypertension Reports.

[6]  A. Briones,et al.  c-Src, ERK1/2 and Rho kinase mediate hydrogen peroxide-induced vascular contraction in hypertension: role of TXA2, NAD(P)H oxidase and mitochondria , 2015, Journal of hypertension.

[7]  S. Laurent,et al.  Dose-Dependent Arterial Destiffening and Inward Remodeling After Olmesartan in Hypertensives With Metabolic Syndrome , 2014, Hypertension.

[8]  P. Katakam,et al.  Diversity of mitochondria-dependent dilator mechanisms in vascular smooth muscle of cerebral arteries from normal and insulin-resistant rats. , 2014, American journal of physiology. Heart and circulatory physiology.

[9]  G. Mitchell Arterial stiffness and hypertension: chicken or egg? , 2014, Hypertension.

[10]  A. Briones,et al.  Lysyl oxidase (LOX) in vascular remodelling , 2014, Thrombosis and Haemostasis.

[11]  M. Metra,et al.  Role of Aliskiren on Arterial Stiffness and Endothelial Function in Patients With Primary Hypertension , 2014, Journal of clinical hypertension.

[12]  L. de las Fuentes,et al.  Williams Syndrome Predisposes to Vascular Stiffness Modified by Antihypertensive Use and Copy Number Changes in NCF1 , 2014, Hypertension.

[13]  S. Dikalov,et al.  Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. , 2013, Antioxidants & redox signaling.

[14]  P. Sarafidis,et al.  Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. , 2013, American journal of hypertension.

[15]  A. Briones,et al.  Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways. , 2013, Toxicology and applied pharmacology.

[16]  Kristian Thygesen,et al.  Small artery structure during antihypertensive therapy is an independent predictor of cardiovascular events in essential hypertension , 2013, Journal of hypertension.

[17]  J. Chen,et al.  Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress , 2013, Hypertension Research.

[18]  K. Griendling,et al.  Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System , 2012, Circulation research.

[19]  P. Nilsson,et al.  Pulse Pressure, Arterial Stiffness, and End-Organ Damage , 2012, Current Hypertension Reports.

[20]  M. Runge,et al.  Mitochondrial Oxidative Stress in Aortic Stiffening With Age: The Role of Smooth Muscle Cell Function , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Jessica E Wagenseil,et al.  Elastin in Large Artery Stiffness and Hypertension , 2012, Journal of Cardiovascular Translational Research.

[22]  P. Clifford,et al.  Spatial Distribution and Mechanical Function of Elastin in Resistance Arteries: A Role in Bearing Longitudinal Stress , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Blacher,et al.  Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle? , 2011, Atherosclerosis.

[24]  Victoria P. Le,et al.  Decreased aortic diameter and compliance precedes blood pressure increases in postnatal development of elastin-insufficient mice. , 2011, American journal of physiology. Heart and circulatory physiology.

[25]  R. Aledo,et al.  Fibulin-5 Is Up-regulated by Hypoxia in Endothelial Cells through a Hypoxia-inducible Factor-1 (HIF-1α)-dependent Mechanism* , 2010, The Journal of Biological Chemistry.

[26]  D. Duprez Is Vascular Stiffness a Target for Therapy? , 2010, Cardiovascular Drugs and Therapy.

[27]  D. Harrison,et al.  Therapeutic targeting of mitochondrial superoxide in hypertension , 2010, Circulation research.

[28]  R. Touyz,et al.  Oxidative Stress and Hypertension: Current Concepts , 2010, Current hypertension reports.

[29]  A. Briones,et al.  Role of extracellular matrix in vascular remodeling of hypertension , 2010, Current opinion in nephrology and hypertension.

[30]  L. Badimón,et al.  Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors. , 2009, Cardiovascular research.

[31]  J. Egido,et al.  Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress , 2009, Hypertension.

[32]  L. Badimón,et al.  Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. , 2008, Cardiovascular research.

[33]  A. Dominiczak,et al.  Vascular stiffness is related to superoxide generation in the vessel wall , 2008, Journal of hypertension.

[34]  A. Rodríguez-Sinovas,et al.  Lysyl oxidase as a potential therapeutic target. , 2008, Drug news & perspectives.

[35]  Hideki Sugitani,et al.  Functional Rescue of Elastin Insufficiency in Mice by the Human Elastin Gene: Implications for Mouse Models of Human Disease , 2007, Circulation research.

[36]  C. Giannarelli,et al.  Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. , 2007, American journal of hypertension.

[37]  SE Greenwald,et al.  Ageing of the conduit arteries , 2007, The Journal of pathology.

[38]  M Carmen González,et al.  Elastic fibres and vascular structure in hypertension. , 2006, Pharmacology & therapeutics.

[39]  A. Briones,et al.  Postnatal alterations in elastic fiber organization precede resistance artery narrowing in SHR. , 2006, American journal of physiology. Heart and circulatory physiology.

[40]  M. Hendrix,et al.  Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. , 2005, Cancer research.

[41]  H. Cai NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. , 2005, Circulation research.

[42]  E. Schiffrin,et al.  Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice , 2004, Journal of hypertension.

[43]  C. de Ciuceis,et al.  Prognostic Significance of Small-Artery Structure in Hypertension , 2003, Circulation.

[44]  Attila Kovacs,et al.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. , 2003, The Journal of clinical investigation.

[45]  J. Giraldo,et al.  Role of Elastin in Spontaneously Hypertensive Rat Small Mesenteric Artery Remodelling , 2003, The Journal of physiology.

[46]  K. Kivirikko,et al.  Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice , 2002, Circulation.

[47]  A. Banerjee,et al.  Evaluation of arterial stiffness in children with Williams syndrome: Does it play a role in evolving hypertension? , 2001, American heart journal.

[48]  D. Sorescu,et al.  Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[49]  H. Kagan,et al.  Hydrogen peroxide‐mediated, lysyl oxidase‐dependent chemotaxis of vascular smooth muscle cells , 2000, Journal of cellular biochemistry.

[50]  R. Weksberg,et al.  Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. , 2000, American journal of human genetics.

[51]  A. Dart,et al.  Spontaneous running increases aortic compliance in Wistar-Kyoto rats. , 1997, Cardiovascular research.

[52]  C. Chichester,et al.  Depressor effect of diabetes in spontaneously hypertensive rat: role of vascular reactivity and prolyl hydroxylase and lysyl oxidase activities. , 1985, Life sciences.

[53]  P. Trackman,et al.  Reaction of aortic lysyl oxidase with beta-aminopropionitrile. , 1983, The Journal of biological chemistry.

[54]  S. Benson,et al.  Increased lysyl oxidase activity in aortas of hypertensive rats and effect of beta-aminopropionitrile. , 1979, Experimental and molecular pathology.

[55]  A. Ooshima,et al.  Increased lysyl oxidase activity in blood vessels of hypertensive rats and effect of beta-aminopropionitrile on arteriosclerosis. , 1978, Japanese circulation journal.

[56]  Z. Ungvari,et al.  CALL FOR PAPERS Mitochondria in Cardiovascular Physiology and Disease Role of mitochondrial oxidative stress in hypertension , 2013 .

[57]  J. Redondo,et al.  Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. , 2013, Antioxidants & redox signaling.

[58]  T. Himoto,et al.  Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients. , 2012, Journal of atherosclerosis and thrombosis.

[59]  T. Himoto,et al.  Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension. , 2012, Journal of atherosclerosis and thrombosis.

[60]  F. Laurindo,et al.  Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products. , 2008, Methods in enzymology.